Bristol-Myers Squibb - M&A Summary and Business Overview

Life ScienceCompany

Bristol-Myers Squibb M&A Summary

Bristol-Myers Squibb has acquired 24 companies, including 7 in the last 5 years. A total of 2 acquisitions came from private equity firms. It has also divested 13 assets.

Bristol-Myers Squibb’s largest acquisition to date was in 2019, when it acquired Celgene for $74.0B. It’s largest disclosed sale occurred in 2001, when it sold Clairol to The Procter & Gamble for $5.0B. Bristol-Myers Squibb has acquired in 8 different US states, and 4 countries. The Company’s most targeted sectors include life science (100%).

Bristol-Myers Squibb Business Overview

Where is Bristol-Myers Squibb headquartered?

Bristol-Myers Squibb is headquartered in Princeton, New Jersey.

What is Bristol-Myers Squibb’s revenue?

Bristol-Myers Squibb disclosed revenue of 45,006M USD for 2023 and 46,159M USD for 2022.

How many employees does Bristol-Myers Squibb have?

Bristol-Myers Squibb has 34,100 employees.

What sector is Bristol-Myers Squibb in?

Bristol-Myers Squibb is a life science company.

When was Bristol-Myers Squibb founded?

Bristol-Myers Squibb was founded in 1887.

M&A Summary

  • M&A Total Activity36
    • M&A Buy Activity23
    • M&A Sell Activity13
  • Total Sectors Invested 1
  • Total Countries Invested 4
  • M&A Buy/Sell Connections 16
  • M&A Advisors 11

Bristol-Myers Squibb

Bristol-Myers Squibb Co.

Route 206 & Province Line Road,
Princeton, New Jersey 08543
United States,
(609) 252-4621
www.bms.com

Bristol-Myers Squibb is a life science company engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products on a global basis. The Company's pharmaceutical products include chemically-synthesized drugs, or small molecules, and an increasing portion of products produced from biological processes. The majority of Bristol-Myers Squibb's revenue comes from products in the following therapeutic classes: cardiovascular; virology, including human immunodeficiency virus (HIV) infection; oncology; neuroscience; immunoscience; and metabolics. Bristol-Myers Squibb was incorporated in 1887 and is based in Princeton, New Jersey.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (1.2/yr) # 17 2 - 1 3 - 23
vol $96.6B $13.1B $4.1B $22.9B $136.7B
Sell (0.4/yr) # 11 1 1 - - - 13
vol $13.0B $13.0B
  36

Most Recent M&A

Company Date Value Type
RayzeBio, Inc. 2023-12-26 4.1B USD Add-on Acquisition
San Diego, California · www.rayzebio.com
Karuna Therapeutics, Inc. 2023-12-22 14.0B USD Add-on Acquisition
Boston, Massachusetts · www.karunatx.com
Mirati Therapeutics, Inc. 2023-10-08 4.8B USD Merger
San Diego, California · www.mirati.com
Turning Point Therapeutics, Inc. 2022-06-03 4.1B USD Add-on Acquisition
San Diego, California · www.tptherapeutics.com
Bristol-Myers Squibb Co. - Drug Product Manufacturing Facility 2021-08-03 - Divestiture
Couvet, Switzerland
Galecto, Inc. 2020-10-28 - IPO
Copenhagen, Denmark · www.galecto.com
MyoKardia, Inc. 2020-10-05 13.1B USD Add-on Acquisition
South San Francisco, California · www.myokardia.com
Formation Biologics, Inc. 2020-08-24 - Add-on Acquisition
Austin, Texas · www.forbius.com
Bristol-Myers Squibb Co. - Anagni Manufacturing Facility 2019-06-19 - Divestiture
Anagni, Italy
Celgene Corp. 2019-01-03 74.0B USD Add-on Acquisition
Summit, New Jersey · www.celgene.com
View All >>

Business Unit M&A

Company Acquired Add-On/Sale Date #
Celgene Corp. 2019-01-03 PharmAkea, Inc. 2020-01-07 2
Summit, New Jersey · www.celgene.com San Diego, California · www.pharmakea.com
Celgene Corp. 2019-01-03 Otezla 2019-08-26 1
Summit, New Jersey · www.celgene.com , United States
IFM Therapeutics 2017-08-03 IFM Tre 2019-04-01 1
Boston, Massachusetts · www.ifmthera.com Boston, Massachusetts

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 23 (100%) 136.7B (100%) 5 (38%) 3.1B (23%)
Medical Products - - 5 (38%) 5.0B (38%)
Consumer Products - - 2 (15%) 5.0B (38%)
Food - - 1 (8%) -
Total 23 $136.7B 13 $13.0B

By Geo

State/Country Buy Value Sell Value
United States 20 136.1B 8 8.9B
  California 9 33.9B - -
  Massachusetts 4 14.7B 1 525M
  New Jersey 2 76.1B - -
  Washington 1 885M - -
  Texas 1 - - -
  North Carolina 1 300M - -
  Georgia 1 2.5B - -
  Delaware 1 7.8B - -
  Ohio - - 1 -
  Indiana - - 1 -
  Illinois - - 1 -
  Florida - - 1 370M
  Connecticut - - 1 5.0B
Denmark 1 - 1 -
United Kingdom 1 475M 1 4.1B
France - - 1 -
Italy - - 1 -
Sweden 1 95M - -
Switzerland - - 1 -
Domestic 20 (87%) 136.1B (100%) 8 (62%) 8.9B (68%)
Cross-border 3 (13%) 570M (< 1%) 5 (38%) 4.1B (32%)
Total 23 $136.7B 13 $13.0B

Top M&A Advisors

Financial Deals
Morgan Stanley
5
Evercore Group
3
Citigroup Investment Banking
3
Legal Deals
Kirkland & Ellis
8
Cravath, Swaine & Moore
4
Covington & Burling
3

Deal Values

buy # Total
> $1B 11 $133.1B
$100M to $1B 7 $3.5B
< $100M 1 $95M
TOTAL $136.7B
Largest Celgene Corp.
$74.0B (2019-01-03)
sell # Total
> $1B 3 $11.8B
$100M to $1B 3 $1.2B
TOTAL $13.0B
Largest Clairol, Inc.
$5.0B (2001-05-22)

M&A Connections

Deals
Acquired from
Investor(s)
4%
1 (4%)
Strategic(s)
4%
1 (4%)
Divested to
Investor(s)
8%
1 (8%)
Strategic(s)
62%
8 (62%)

 Subscribe to unlock this and 204,613
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 196K M&A Transactions
  • 200K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 78K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.